3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
7
Urinary Bladder Neoplasms
5
Glioma
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Esophageal Neoplasms
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
venetoclax
28
Cytarabine
25
Azacitidine
23
Specimen Handling
21
fludarabine
15
Biopsy
13
Injections
12
Daunorubicin
11
Cyclophosphamide
11
fludarabine phosphate
10
decitabine and cedazuridine drug combination
9
Whole-Body Irradiation
9
CPX-351
8
Mycophenolic Acid
7
Idarubicin
7
Granulocyte Colony-Stimulating Factor
7
Gemtuzumab
7
ivosidenib
6
Tacrolimus
6
Stem Cell Transplantation
6
Filgrastim
6
Busulfan
6
enasidenib
5
X-Rays
5
Melphalan
5
Etoposide
5
Decitabine
5
Cyclosporine
5
ruxolitinib
4
olutasidenib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Acute
×
Radiation
×
30 days
×
Clear all
No trials found.